A healthy hemophilic patient without arthropathy: From concept to clinical reality

Seminars in Thrombosis and Hemostasis

Volumn 29, Issue 1, 2003, Pages 5-10

  Berntorp, Erik ^a,b   Michiels, Jan J ^c,d  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c Goodheart Institute   (Netherlands)

^d ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Factor VIII; Gene therapy; Hemophilia; Inhibitor; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR 8; RECOMBINANT DNA;

ARTHROPATHY; BLEEDING; GENE TECHNOLOGY; GENE THERAPY; HEMOPHILIA; HEREDITY; HUMAN; IMMUNOLOGICAL TOLERANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; X RAY;

EID: 0037325249     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-37934     Document Type: Review

References (34)

1. Pavlovsky A. Contribution to the pathogenesis of haemophilia. Blood 1947;2:185-191
2. Biggs R, Douglas AS, Macfarlane RG, et al. Christmas disease: a condition previously mistaken for haemophilia. BMJ 1952;2:1378-1382
3. Ahlberg Å. Haemophilia in Sweden. VII. Incidence, treatment and prophylaxis of arthropathy and other musculoskeletal manifestations of haemophilia A and B. Acta Orthop Scand 1965;(Suppl 77):7-80
4. White GC, Rosendaal F, Aledort LM, et al. Definitions in haemophilia. Thromb Haemost 2001;85:560
5. Kemball-Cook G, Tuddenham EGD. The molecular defect in hemophilia A. In: Forbes CD, Aledort L, Madhok R, eds. Hemophilia. London: Chapman & Hall; 1997:21-33
6. Roberts HR, Liles DK. The molecular biology of hemophilia B. In: Forbes CD, Aledort L, Madhok R, eds. Hemophilia. London: Chapman & Hall; 1997:35-50
7. Ginsburg D. Molecular genetics of hemophilia. In: Hematology 2000. Washington, D.C.: American Society of Hematology; 2000:241-246
8. Rosendaal FR, Smith C, Briet E. Haemophilia treatment in historical perspective: a review of medical and social developments. Ann Hematol 1991;62:5-15
9. Nilsson IM. History and demography of hemophilia with special reference to the situation in Sweden. In: Hemophilia. Stockholm: Pharmacia Plasma Products; 1994:2-5
10. Triemstra AHM, Smit C, van der Ploeg HM, Briët E, Rosendaal FR. Two decades of haemophilia treatment in the Netherlands, 1972-92. Haemophilia 1995;1:165-171
11. Liesner RJ, Khair K, Hann IM. The impact of prophylactic treatment on children with severe haemophilia. Br J Haematol 1996;92:973-978
12. Nilsson IM, Hedner U, Ahlberg Å. Haemophilia prophylaxis in Sweden. Acta Paediatr Scand 1976;65:129-135
13. Berntorp E. Methods of haemophilia care delivery: regular prophylaxis versus episodic treatment. Haemophilia 1995;1 (Suppl 1):3-7
14. Nilsson IM, Blombäck M, Ahlberg Å. Our experience in Sweden with prophylaxis on haemophilia. Proceedings of the 5th Congress of the World Federation of Haemophilia, Montreal 1968; Bibl Haematol, No. 34, New York: Karger; 1970:111-124
15. Pettersson H, Ahlberg Ä, Nilsson IM. A radiologic classification of haemophilic arthropathy. Clin Orthop 1980;149:153-159
16. Nilsson IM, Berntorp E, Löfqvist T, Pettersson H. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Intern Med 1992;232:25-32
17. Nilsson IM. Replacement therapy. In: Hemophilia. Stockholm: Pharmacia Plasma Products; 1994:30-49
18. Pettersson H, Gilbert M. Diagnostic Imaging in Haemophilia: Musculoskeletal and Other Haemorrhagic Complications. Berlin: Springer-Verlag; 1985:56-65
19. Fischer K. Treatment Strategies for Severe Haemophilia. In Search of the Optimal Treatment. Utrecht, The Netherlands: University of Utrecht; 2001. Thesis
20. Aledort LM, Haschenmeyer RH, Pettersson H. A longitudinal study of orthopaedic outcomes for severe factor VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group. J Intern Med 1994;236:391-399
21. Szucs TD, Öffner A, Schramm W. Socioeconomic impact of haemophilia care: results of a pilot study. Haemophilia 1996;2:211-217
22. Carlsson M, Björkman S, Berntorp E. Multidose pharmacokinetics of factor IX: implications for dosing in prophylaxis. Haemophilia 1998;4:83-88
23. Carlsson M, Berntorp E, Björkman S, Lindvall K. Pharmaco-kinetic dosing in prophylactic treatment of hemophilia A. Eur J Haematol 1993;51:247-252
24. Astermark J, Berntorp E, White GC, Kroner BL, and the MIBS Study Group. The Malmö International Brother Study (MIBS): further support for genetic predisposition to inhibitor development. Haemophilia 2001;7:267-271
25. Brackmann JH, Gormsen J. Massive factor VIII infusion in haemophiliacs with factor VIII inhibitor, high responder. Lancet 1977;2:933
26. Mauser-Bunschoten EP, Nieuwenhuis HK, Roosendaal G, van den Berg M. Low-dose immune tolerance induction in hemophilia A patients with inhibitors. Blood 1995;86:983-988
27. Ewing NP, Sander NL, Dietrich SL, Kasper CK. Induction of immune tolerance to factor VIII in hemophiliacs with inhibitors. JAMA 1988;259:65-68
28. Nilsson IM, Berntorp E, Zettervall O. Induction of immune tolerance in patients with hemophilia and antibodies to factor VIII by combined treatment with intravenous IgG, cyclophosphamide, and factor VIII. N Engl J Med 1988;318:947-950
29. Mariani G, Kroner B. International Immune Tolerance Registry, 1997 Update. Vox Sang 1999;77(Suppl 1):25-27
30. DiMichele DM, Kroner BL. Analysis of the North American Immune Tolerance Registry (NAITR) 1993-1997: current practice implications. Vox Sang 1999;77(Suppl 1):31-32
31. Key NS, Aledort LM, Beardsley D, et al. Home treatment of mild and moderate episodes using recombinant factor VIIa (Novoseven) in hemophiliacs with inhibitors. Thromb Haemost 1998;80:912-918
32. Négrier C, Goudemand J, Sultan Y, et al. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. Thromb Haemost 1997;77:1113-1119
33. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in patients with inhibitors undergoing surgery. Thromb Haemost 1998;80:773-778
34. White GC. Gene therapy in hemophilia: clinical trials up-date. Thromb Haemost 2001;86:172-177